Search results
Results from the WOW.Com Content Network
In March 2020, Thermo Fisher Scientific received emergency use authorization from the FDA for a test for SARS-CoV-2 to help mitigate the COVID-19 pandemic. [citation needed] Thermo Fisher also partnered with its biopharma customers, including Pfizer and Moderna, to support the development and production of new mRNA-based COVID-19 vaccines. [49 ...
Contact us; Contribute Help; ... Number of employees. 40,000+ (2023) ... Thermo Fisher Scientific completes the acquisition of PPD. [20] Location
[citation needed] In November 2006, Thermo Electron and Fisher Scientific International merged to form Thermo Fisher Scientific (TFS). [2] [better source needed] Today, the company formerly known as Pierce Chemical Company and Pierce Biotechnology Inc. is the TFS research and development division, "Thermo Scientific Pierce Protein Biology". [3]
On May 27, 2016, Thermo Fisher Scientific Inc. announced [9] its acquisition of FEI Company for US$4.2 billion, which commenced in early 2017. [10] At the time of the transaction, FEI had more than 2700 employees in over 20 countries. [11] The FEI trademark was phased out in favor of the Materials & Structural Analysis division of Thermo Fisher ...
Patheon is a service brand within Thermo Fisher Scientific's brand portfolio.Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging.
The latter was acquired by Thermo Fisher Scientific in 2014. Prior to 2008, the Applied Biosystems brand was owned by various entities in a corporate group parented by PerkinElmer. The roots of Applied Biosystems trace back to GeneCo (Genetic Systems Company), a pioneer biotechnology company founded in 1981 in Foster City, California. [1]
Thermo Electron Corporation (NYSE: TMO) (incorporated 1956) was a major provider of analytical instruments and services for a variety of domains. It was co-founded in 1956 by George N. Hatsopoulos , an MIT PhD in mechanical engineering , and Peter M. Nomikos, a Harvard Business School graduate, who provided initial funding.
Invitrogen is one of several brands under the Thermo Fisher Scientific corporation. The product line includes various subbrands of biotechnology products, such as machines and consumables for polymerase chain reaction, reverse transcription, cloning, culturing, stem cell production, cell therapy, regenerative medicine, immunotherapy, transfection, DNA/RNA purification, diagnostic tests ...